Among the commonly down-regulated transcripts, we found enrichment in SRSF6-regulated and type 2 diabetes pathways, pointing to SRSF6-mediated splicing modifications in IFNα-treated EndoC-βH1 cells (Fig 4C, left panel). This evidence concerns the gene SRSF6 and type 2 diabetes mellitus.